Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Advancing drug discovery and gaining competitive advantage through user experience (UX)


Published on

In this talk you will:
- Hear about the internal UX design capabilities of nine global research-based biopharmaceutical companies from a new investigation carried out in 2017
- Find out how your organisation can benefit from a free UX toolkit for life science R&D designed by the Pistoia Alliance “User Experience for Life Sciences” (UXLS) initiative, a feat which involved over 50 UX design experts from 20 life science and tech organisations
- Discover how UX offers a clear path to differentiating your business and reaping benefits for the discovery pipeline through specific case studies of UX in R&D

Speaker Bio:
Jennifer Cham, Lead User Experience Designer, EMBL-EBI
Jenny Cham is a proteomics scientist turned User Experience Designer, who founded the UX design capability at the European Bioinformatics Institute (EMBL-EBI) in 2009. She has over ten years’ experience of delivering digital solutions specifically for complex data-driven biomedical research. Alongside her day job, is involved in the User Experience for Life Science project coordinated by the Pistoia Alliance.

As a UX and digital design evangelist, Jenny writes articles and blogs about UX design for science. Her passion for “game-storming”-style workshops, design studios and graphic recording (aka “sketchnoting”) have all contributed to increasing stakeholder and user engagement in the design process, and build a community of UX early adopters in the pharmaceutical industry.

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

Advancing drug discovery and gaining competitive advantage through user experience (UX)

  1. 1. Source: Flickr Mark Doliner
  2. 2. Source: Realizing the Promise of Precision Medicine, Health Catalyst
  3. 3. Source: Kerry Bodine
  4. 4. Source: Apps4Kids Hackathon 2015 Source: Shutterstock
  5. 5. Source: Pat Keller Novartis NIBR
  6. 6. Source: Pat Keller Novartis NIBR
  7. 7. Source: Pat Keller Novartis NIBR
  8. 8. 0 0.0002 0.0004 0.0006 0.0008 0.001 0.0012 A B C D E F G H I RatioofUXFTEsinR&Dpertotalcompany headcount Large R&D-based biopharmaceutical companies
  9. 9. Source:
  10. 10. Source:
  11. 11. Source: Source: Wikimedia Commons
  12. 12. Source: Forrester courtesy of TandemSeven
  13. 13. Source: Forrester courtesy of TandemSeven
  14. 14. @JenniferCham jennifer.cham@ebi.acuk